Fig. 5From: PD-L1 expressing circulating tumour cells in head and neck cancersRange of expression of PD-L1 across 5 HNC cell lines (FaDu, SCC25, CAL27, SCC15, 93-Vu-147 T), negative control (K562) and patient sample (HNC01)Back to article page